Bladder Cancer | Siamak Daneshmand, MD

The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer — Faculty Presentation #2: Immune Checkpoint Inhibitors as Neoadjuvant and Adjuvant Therapy for Muscle-Invasive Bladder Cancer — Dr Daneshmand CME information and select publications